<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002880'>Respiratory difficulties</z:hpo> and breathing disorders in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> are thought to underlie the increased risk for sudden infant <z:hpo ids='HP_0011420'>death</z:hpo> and neuropsychological deficits seen in this condition </plain></SENT>
<SENT sid="1" pm="."><plain>This review evaluates literature regarding respiratory dysfunctions and their sequelae in patients with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The limited number of prospective studies of <z:e sem="disease" ids="C0035204" disease_type="Disease or Syndrome" abbrv="">respiratory disease</z:e> in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> means that observational studies and case series provide a large proportion of the data regarding the spectrum of <z:e sem="disease" ids="C0035204" disease_type="Disease or Syndrome" abbrv="">respiratory diseases</z:e> in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> and their treatments </plain></SENT>
<SENT sid="3" pm="."><plain>Amongst clinical respiratory problems described, snoring is the commonest observed abnormality, but the reported incidence of obstructive <z:hpo ids='HP_0010535'>sleep apnoea</z:hpo> (OSA) shows wide variance (10% to 75%) </plain></SENT>
<SENT sid="4" pm="."><plain>Reported treatments of OSA include adenotonsillectomy, the use of CPAP, and surgical improvement of the airway, including mid-face advancement </plain></SENT>
<SENT sid="5" pm="."><plain>Otolaryngologic manifestations are also common </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002093'>Respiratory failure</z:hpo> due to small thoracic volumes is reported, but uncommon </plain></SENT>
<SENT sid="7" pm="."><plain>Mortality rate at <z:hpo ids='HP_0000001'>all</z:hpo> ages was 2.27 (CI: 1.7-3.0) with age-specific mortality increased at <z:hpo ids='HP_0000001'>all</z:hpo> ages </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0001699'>Sudden death</z:hpo> was most common in infants and children </plain></SENT>
<SENT sid="9" pm="."><plain>Cardiovascular events are the main cause of mortality in adults </plain></SENT>
<SENT sid="10" pm="."><plain>Despite earlier recognition and treatment of respiratory complications of <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e>, increased mortality rates and other complications remain high </plain></SENT>
<SENT sid="11" pm="."><plain>Future and ongoing evaluation of the prevalence and impact of <z:e sem="disease" ids="C0035204" disease_type="Disease or Syndrome" abbrv="">respiratory disorders</z:e>, particularly OSA, in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> is recommended </plain></SENT>
</text></document>